Unicycive Therapeutics, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
UNCY on Nasdaq
Location
4300 El Camino Real, Suite 210, Los Altos, CA

There are no Buy or Sell transactions made by insiders since 10/17/2024

Unicycive Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gaurav Aggarwal Director $7.61M Aug 25, 2025
Brigitte Schiller Director $34.4K Jul 15, 2022
Douglas Jermasek EVP of Corporate Strategy Jul 28, 2025
John Townsend Chief Financial Officer Jul 28, 2025
John Ryan Director Sep 5, 2023
Sandeep Laumas Director Jul 28, 2025
Sara Kenkare-Mitra Director Jul 28, 2025
Pramod Gupta EVP, Pharmaceuticals and BD Jul 28, 2025
Shalabh Gupta CEO, Director Jul 28, 2025

Recent Insider Transactions by Companies or Individuals for Unicycive Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.